Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Stock-Based Compensation Expense) (Details)

v3.24.1.1.u2
Stockholders' Equity (Stock-Based Compensation Expense) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 4,857 $ 4,731
Avenue Therapeutics, Inc [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 191 11
Checkpoint [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 709 969
Mustang    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 77 235
Journey    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 1,406 646
Other Partners [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 57 26
Employee and non-employee awards    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense 2,193 2,437
Executive awards    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock-based compensation expense $ 224 $ 407